Stewart Gull, John Turner, and Stewart’s daughter Shelley Hindhaugh
The Fiona Elsey Cancer Research Institute has launched a state of the art mass spectrometer, a significant step forward in what its scientists can see, measure and understand.
This technology allows researchers to analyse the molecules that drive cancer with extraordinary precision. It can detect subtle changes in proteins, metabolites and other biomarkers, helping scientists better understand how cancer develops, responds to treatment and, importantly, how it can be stopped.
For FECRI, it means clearer answers, faster progress and new opportunities to push research further.
A gift that becomes capability
This milestone has been made possible through the extraordinary generosity of John Turner and the Gull family, whose $500,000 gift brought this technology to life.
Their support was matched by Bruker, whose commitment ensured the instrument and its components were supplied well below market value, maximising the impact of every dollar invested.
Professor George Kannourakis, Director of FECRI, said the impact is immediate.
“The new mass spectrometer lifts the ceiling on what we can measure and how quickly we can measure it. That generosity translates directly into scientific capability for regional Australia.”
For a regional, community funded institute, this is not just new equipment. It is new momentum.
With deep gratitude
There are moments in an organisation’s life that mark a shift.
This is one of them.
To John Turner and the Gull family, thank you. Your belief in what is possible has created real and lasting impact.
To Bruker, thank you for standing behind that belief.
Because of you, the scientists at FECRI can move faster, look deeper and push further in the pursuit of answers.
And for the people who will one day benefit from those answers, this matters more than words can say.
